← Evidence map

ArticleThe oncologist2026

Correction to: Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41866820